Literature DB >> 12829453

Nasal airway ion transport and lung function in young people with cystic fibrosis.

Helen L Wallace1, Pierre M Barker, Kevin W Southern.   

Abstract

There is strong evidence that abnormal airway ion transport is the primary defect that initiates the pathophysiology of lung disease in cystic fibrosis (CF). To examine the relationship between airway ion transport abnormality and severity of lung disease, we measured nasal potential difference in 51 young people with CF using a validated modified technique. There was no correlation between any component of the ion transport measurement and clinical condition (respiratory function, chest radiograph score, or Shwachman clinical score). Thirty subjects, homozygous for the DeltaF508 mutation, were divided into those above and those below average respiratory function for their age. There was no significant difference in any of the ion transport parameters between those with above and below average pulmonary function. Of the 51 subjects, 10 had significant hyperpolarization after perfusion with a zero Cl- solution (> 5 mV). This Cl- secretory capacity did not correlate with above average lung function. These data do not support the assertion that the extent of lung disease in CF reflects the degree of ion transport abnormality. We suggest that although an ion transport abnormality initiates lung disease, other factors (e.g., environmental and genetic modifiers) are more influential in determining disease severity.

Entities:  

Mesh:

Year:  2003        PMID: 12829453     DOI: 10.1164/rccm.200211-1302OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

1.  Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients.

Authors:  I Fajac; D Hubert; D Guillemot; I Honoré; T Bienvenu; F Volter; J Dall'Ava-Santucci; D J Dusser
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

Review 2.  Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials.

Authors:  Steven M Rowe; Frank Accurso; John P Clancy
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

3.  Measurements of CFTR-mediated Cl- secretion in human rectal biopsies constitute a robust biomarker for Cystic Fibrosis diagnosis and prognosis.

Authors:  Marisa Sousa; Maria F Servidoni; Adriana M Vinagre; Anabela S Ramalho; Luciana C Bonadia; Verónica Felício; Maria A Ribeiro; Inna Uliyakina; Fernando A Marson; Arthur Kmit; Silvia R Cardoso; José D Ribeiro; Carmen S Bertuzzo; Lisete Sousa; Karl Kunzelmann; Antônio F Ribeiro; Margarida D Amaral
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

4.  Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data.

Authors:  Frank J Accurso; Fredrick Van Goor; Jiuhong Zha; Anne J Stone; Qunming Dong; Claudia L Ordonez; Steven M Rowe; John Paul Clancy; Michael W Konstan; Heather E Hoch; Sonya L Heltshe; Bonnie W Ramsey; Preston W Campbell; Melissa A Ashlock
Journal:  J Cyst Fibros       Date:  2014-03       Impact factor: 5.527

5.  Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control study.

Authors:  Azadeh Bagheri-Hanson; Sebastian Nedwed; Claudia Rueckes-Nilges; Lutz Naehrlich
Journal:  BMC Pulm Med       Date:  2014-10-04       Impact factor: 3.317

6.  Repeatability and Diagnostic Value of Nasal Potential Difference in a Genetically Admixed Population.

Authors:  Izabela Rocha Sad; Laurinda Yoko Shinzato Higa; Teresinha Leal; Raisa da Silva Martins; Ana Claudia de Almeida; Eloane Goncalves Ramos; Giselda Maria Kalil de Cabello; Maria Virginia Marques Peixoto
Journal:  J Clin Med Res       Date:  2015-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.